Gene: DACT1
Official Full Name: dishevelled binding antagonist of beta catenin 1provided by HGNC
Gene Summary: The protein encoded by this gene belongs to the dapper family, characterized by the presence of PDZ-binding motif at the C-terminus. It interacts with, and positively regulates dishevelled-mediated signaling pathways during development. Depletion of this mRNA from xenopus embryos resulted in loss of notochord and head structures, and mice lacking this gene died shortly after birth from severe posterior malformations. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22625 | DACT1 Knockout cell line (HCT 116) | Human | DACT1 | 1:2~1:4 | Negative | Online Inquiry |
KO22626 | DACT1 Knockout cell line (HEK293) | Human | DACT1 | 1:3~1:6 | Negative | Online Inquiry |
DACT1 Gene Knockout Cell Lines are genetically engineered cell lines that have undergone precise deletion of the Dishevelled-Associated Activator of Morphogenesis 1 (DACT1) gene. This product enables the study of DACT1's role in various biological processes, particularly in developmental biology and cancer research. By creating a controlled environment where DACT1 is absent, researchers can explore the downstream effects on pathways such as Wnt signaling, which plays a critical role in cellular proliferation, differentiation, and apoptosis.
The primary function of DACT1 is to modulate Wnt signaling, acting as a negative regulator. By removing DACT1 through knockout strategies, users can investigate how the absence of this gene affects various cellular outcomes, such as gene expression profiles and phenotypic alterations. The mechanism involves alterations in β-catenin stabilization and subsequent translocation to the nucleus, prompting insights into tumorigenesis and stem cell maintenance.
These knockout cell lines hold significant scientific importance for researchers focused on elucidating the complexities of signaling pathways in health and disease. In clinical applications, they can be employed in drug discovery, providing a platform to test therapeutic agents targeting Wnt-related pathways in conditions like cancer and other proliferative disorders.
Compared to alternative products, DACT1 Gene Knockout Cell Lines offer a high degree of specificity, validated gene deletion, and reproducibility—fundamental attributes that enhance the reliability of experimental outcomes. Additionally, the use of these knockout models can accelerate research timelines by streamlining gene function analysis and facilitating more accurate in vitro studies.
For researchers, clinicians, and institutions dedicated to advancing molecular biology, DACT1 Gene Knockout Cell Lines signify a pivotal tool in the quest to unravel complex biological interactions. Our company has a proven track record in producing high-quality biological research tools, ensuring user-friendly protocols and comprehensive support to aid in experimental design and execution.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.